QBiotics' continuous product development pipeline is broadly diversified, aimed at improving both human and animal quality of life.
QBiotics invests in a comprehensive development and clinical trial programme to prove the clinical efficacy of our pharmaceutical products and therefore any products that have not been through this rigorous research process can not be endorsed by QBiotics. Currently, tigilanol tiglate is not commercially available.
Tigilanol tiglate was discovered using QBiotics' proprietary EcoLogicTM discovery platform. Tigilanol tiglate (EBC-46) is developed exclusively by QBiotics Group Ltd in Australia using a sophisticated and precise manufacturing process.